Pharmacokinetics of linezolid in critically ill patients

High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid

(2015) Yi-Min Zhang et al.   Hepatobiliary & Pancreatic Diseases International

Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice?

(2015) Francesco Scaglione   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents

(2014) Stijn I. Blot et al.   ADVANCED DRUG DELIVERY REVIEWS

Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients

(2014) Mona I. El-Assal et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid

(2014) M. Bassetti et al.   CLINICAL MICROBIOLOGY AND INFECTION

Interethnic Differences in Pharmacokinetics of Antibacterials

(2014) Danny Tsai et al.   CLINICAL PHARMACOKINETICS

How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?

(2014) T.W. Felton et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration

(2014) Gennaro De Pascale et al.   INTENSIVE CARE MEDICINE

Continuous administration of linezolid in pneumonia: what is the level of proof?

(2014) Olivier Mimoz et al.   INTENSIVE CARE MEDICINE

Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections

(2014) S. Luque et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients

(2013) Tatsuya Yagi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia

(2012) E. Boselli et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Definitions and Epidemiology of the Chronically Critically Ill

(2012) Shannon S Carson   Respiratory Care

Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections

(2012) Irma Hoyo et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections UsingIn VivoMicrodialysis

(2011) Dora E. Wiskirchen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill Intensive Care Unit patients

(2011) Haiyan Dong et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

(2010) R. Nau et al.   CLINICAL MICROBIOLOGY REVIEWS

Aqueous and Vitreous Penetration of Linezolid and Levofloxacin After Oral Administration

(2010) Jomy M. George et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Pharmacokinetics of linezolid in septic patients with and without extended dialysis

(2009) Stefanie Swoboda et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Linezolid

(2008)   TUBERCULOSIS

Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion

(2007) Chiara Adembri et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS